latisse

Cosmetics Drugs Gone Too Far: Is Anything Still Real?

July 14, 2010 · Posted in Daily Health News · Comments Off 

There is something about the new cosmetic “option” for thicker eyelashes that bothers me, though I’m not sure what it is. Perhaps it’s the resistance I still feel after leaving behind those false lashes I wore while modeling with Wilhelmina in the 70s.

Here is the original post:
Cosmetics Drugs Gone Too Far: Is Anything Still Real?

Glaucoma eye drops drug Latisse used OTC to make long eyelashes but some now face side effects

July 13, 2010 · Posted in Daily Health News · Comments Off 

From the NYTimes:Latisse is the same formula as Lumigan, Allergan’s eyedrops for glaucoma, which reduces eye pressure but also happens to grow lashes. Both are also known as bimatoprost ophthalmic solution.

Go here to read the rest:
Glaucoma eye drops drug Latisse used OTC to make long eyelashes but some now face side effects

Latisse Faces Patent Challenge

July 13, 2010 · Posted in Daily Health News · Comments Off 

The FDA said a company is challenging Allergan’s patent protection for the eyelash drug Latisse, looking to make a generic version. (Source: WSJ.com: Health)

See original here:
Latisse Faces Patent Challenge

LATISSE (Bimatoprost) Solution/ Drops [Physicians Total Care, Inc.]

July 6, 2010 · Posted in Daily Health News · Comments Off 

Updated Date: Jul 6, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

Here is the original post:
LATISSE (Bimatoprost) Solution/ Drops [Physicians Total Care, Inc.]

Latisse-Induced Periocular Skin Hyperpigmentation [Small Case Series]

June 14, 2010 · Posted in Daily Health News · Comments Off 

(Source: Archives of Opthalmology)

Visit link:
Latisse-Induced Periocular Skin Hyperpigmentation [Small Case Series]

Long Lashes Without Prescription, but With Risks

May 1, 2010 · Posted in Daily Health News · Comments Off 

A glaucoma eyedrop, reinvented, is routinely available without a doctor’s prescription or visit. (Source: NYT Health)

More here:
Long Lashes Without Prescription, but With Risks

From Serendipity to Pilot Study and Then Pivotal Trial: Bimatoprost Topical for Eyelash Growth

April 1, 2010 · Posted in Daily Health News · Comments Off 

Dr. Cohen has been a consultant and clinical trial investigator for Allergan (including related to Latisse).

Read the original:
From Serendipity to Pilot Study and Then Pivotal Trial: Bimatoprost Topical for Eyelash Growth

Latisse: The answer for longer, thicker eyelashes?

March 26, 2010 · Posted in Daily Health News · Comments Off 

Latisse promotes longer, thicker, darker eyelashes, but causes side effects, too. (Source: MayoClinic.com Full Feed)

Original post:
Latisse: The answer for longer, thicker eyelashes?

LATISSE (Bimatoprost) Solution/ Drops [Allergan, Inc.]

February 28, 2010 · Posted in Daily Health News · Comments Off 

Updated Date: Mar 1, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)) MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network , and receive $5 free advertising.

View original post here:
LATISSE (Bimatoprost) Solution/ Drops [Allergan, Inc.]

US Leading Dermatologists Review Latisse® Benefits for Eyelash Growth

January 4, 2010 · Posted in Daily Health News · Comments Off 

Dermatologists provide their expert opinion regarding the benefits and safety of Latisse

US Leading Dermatologists Review Latisse® Benefits for Eyelash Growth

January 4, 2010 · Posted in Daily Health News · Comments Off 

Dermatologists provide their expert opinion regarding the benefits and safety of Latisse

Policy & Practice: Want more health reform news? Subscribe to our podcast – search “Policy & Practice� in the iTunes store

December 31, 2009 · Posted in Daily Health News · Comments Off 

The National Cancer Institute and the pharmaceutical maker Allergan Inc. are jointly supporting a trial to determine whether bimatoprost (Latisse) can stimulate regrowth of eyelashes and eyebrows after their loss in chemotherapy. The company told a Food and Drug Administration advisory committee in December 2008 that it would explore that potential use of the drug.

See the original post here:
Policy & Practice: Want more health reform news? Subscribe to our podcast – search “Policy & Practice� in the iTunes store

« Previous PageNext Page »